Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K29 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K29 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K39 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K39 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Phosphorylation N Y46 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K47 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Skin cutaneous melanoma Phosphorylation N S58 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Lung squamous cell carcinoma Ubiquitination N K62 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Skin cutaneous melanoma Ubiquitination N K62 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Head and neck squamous cell carcinoma Ubiquitination N K82 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Colon adenocarcinoma Ubiquitination N K97 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Lung adenocarcinoma Ubiquitination N K97 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K97 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Colon adenocarcinoma Phosphorylation N T101 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Lung adenocarcinoma Phosphorylation N T101 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Phosphorylation N T101 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Colon adenocarcinoma Phosphorylation N S102 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Lung adenocarcinoma Phosphorylation N S102 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Phosphorylation N S102 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Phosphorylation N Y114 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Breast invasive carcinoma Phosphorylation N S357 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Ovarian adenocarcinoma Phosphorylation N S357 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Stomach adenocarcinoma Phosphorylation N S357 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Bladder urothelial carcinoma Ubiquitination N K362 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Breast invasive carcinoma Ubiquitination N K362 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Ovarian adenocarcinoma Ubiquitination N K362 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K362 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Bladder urothelial carcinoma Ubiquitination N K370 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K370 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Lung adenocarcinoma Ubiquitination N K377 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K377 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Bladder urothelial carcinoma Ubiquitination N K390 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K390 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Bladder urothelial carcinoma Phosphorylation N S393 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Phosphorylation N S393 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Colon adenocarcinoma Ubiquitination N K412 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Colon adenocarcinoma Ubiquitination N K414 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Paraplegia Ubiquitination N K440 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Skin cutaneous melanoma Ubiquitination N K440 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Stomach adenocarcinoma Ubiquitination N K440 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K440 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Breast invasive carcinoma Ubiquitination N K447 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Paraplegia Ubiquitination N K447 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Stomach adenocarcinoma Ubiquitination N K447 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Breast invasive carcinoma Ubiquitination N K451 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Stomach adenocarcinoma Ubiquitination N K451 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Breast invasive carcinoma Ubiquitination N K455 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Colon adenocarcinoma Ubiquitination N K455 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Uterine corpus endometrial carcinoma Ubiquitination N K455 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Colon adenocarcinoma Ubiquitination N K465 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Stomach adenocarcinoma Ubiquitination N K465 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K465 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Uterine corpus endometrial carcinoma Ubiquitination N K465 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Stomach adenocarcinoma Phosphorylation N S470 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Phosphorylation N S470 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Stomach adenocarcinoma Ubiquitination N K475 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K475 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Stomach adenocarcinoma Ubiquitination N K481 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Prostate adenocarcinoma Ubiquitination N K507 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K507 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Esophageal adenocarcinoma Ubiquitination N K514 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Hepatocellular carcinoma Ubiquitination N K514 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Prostate adenocarcinoma Ubiquitination N K514 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Breast invasive carcinoma Ubiquitination N K519 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Esophageal adenocarcinoma Ubiquitination N K519 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Hepatocellular carcinoma Ubiquitination N K519 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Breast invasive carcinoma Phosphorylation N S524 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Esophageal adenocarcinoma Phosphorylation N S524 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Hepatocellular carcinoma Phosphorylation N S524 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Breast invasive carcinoma Ubiquitination N K526 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Esophageal adenocarcinoma Ubiquitination N K526 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Breast invasive carcinoma Ubiquitination N K527 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Esophageal adenocarcinoma Ubiquitination N K527 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Osteosarcoma SUMOylation N K578 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome SUMOylation N K578 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Osteosarcoma Ubiquitination N K578 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K578 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Esophageal adenocarcinoma Ubiquitination N K615 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Non-Hodgkin's lymphoma Ubiquitination N K615 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K615 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Rectum adenocarcinoma Ubiquitination N K651 Q8N0X7 23111 SPART KIAA0610 SPG20 TAHCCP1 Troyer syndrome Ubiquitination N K651